Metrics as of 10/13/2026, 06:47 PM (Berlin time), refresh in progress.
MiMedx Group Stock
MiMedx Group, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Joseph H. Capper
- Employees
- 808
- Market cap
- $686 M
- IPO
- 12/02/2008
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological…
MiMedx Group stock: price history
1D
-2.2%
1W
+2.2%
1M
+3.3%
6M
+20.5%
YTD
-30.2%
1Y
-27.5%
2Y
-17.3%
5Y
-20.1%
10Y
-43.1%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~0% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BearishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about MiMedx Group
Analyst assessment of MiMedx Group
PRICE TARGET LOW
US$7.00
CONSENSUS
US$7.67
MEDIAN
US$8.00
PRICE TARGET HIGH
US$8.00
0
STRONG BUY
12
BUY
1
HOLD
2
SELL
0
STRONG SELL
15
TOTAL · Buy
As of: 27/08/2026
MiMedx Group stock metrics
P/E
117.68
P/B
3.22
EV/EBITDA
23.29
RETURN ON EQUITY
-6.9%
NET MARGIN
-23.1%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
79.2%
FLOAT SHARES
115,435,003
AVG. DAILY VOLUME (30D)
1,060,133
Insider transactions (SEC)
DOUG RICE
Maersk-Moller Kimberly
Olson Tiffany
HAWKINS WILLIAM A
Newton Todd
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about MiMedx Group stock
What does MiMedx Group do?
MiMedx Group, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Joseph H. Capper, the company employs around 808 people.
The IPO was on 12/02/2008; the stock trades on NASDAQ under the ticker MDXG.
What do analysts say about MiMedx Group stock?
15 analysts rate the stock, the consensus is Buy (as of 27/08/2026).
The average price target is US$7.67, ranging from US$7.00 to US$8.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does MiMedx Group report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 0% stronger than usual.
Does MiMedx Group pay a dividend?
No, MiMedx Group currently does not pay a dividend.
Which stocks are comparable to MiMedx Group?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get MiMedx Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess MiMedx Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.